
CAS 301326-22-7
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 Produkte.
1-Methyl-N-[2-methyl-4-[2-(2-methylphenyl)diazenyl]phenyl-1H-pyrazole-5-carboxamide
CAS:Formel:C19H19N5OReinheit:98%Farbe und Form:SolidMolekulargewicht:333.38711-Methyl-N-(2-Methyl-4-(o-Tolyldiazenyl)Phenyl)-1H-Pyrazole-5-Carboxamide
CAS:1-Methyl-N-(2-Methyl-4-(o-Tolyldiazenyl)Phenyl)-1H-Pyrazole-5-CarboxamideReinheit:98%Molekulargewicht:333.39g/molCH-223191
CAS:Formel:C19H19N5OReinheit:>97.0%(HPLC)(qNMR)Farbe und Form:White to Light yellow to Light orange powder to crystalMolekulargewicht:333.40CH-223191
CAS:CH-223191, a specific aryl hydrocarbon receptor (AhR) antagonist, inhibited TCDD-induced luciferase activity with an IC50 of 0.03 μM. High-Quality, Low-Cost!Formel:C19H19N5OReinheit:99.01% - 99.71%Farbe und Form:SolidMolekulargewicht:333.39CH 223191
CAS:Kontrolliertes Produkt<p>Applications CH 223191 is a novel antagonist of the aryl hydrocarbon receptor.<br>References Choi, E., et. al.: Mol. Pharmacol., 81, 3 (2012)<br></p>Formel:C19H19N5OFarbe und Form:NeatMolekulargewicht:333.39CH-223191
CAS:<p>CH-223191 is a potent and selective DNA polymerase chain reaction (PCR) antagonist that prevents the synthesis of double-stranded DNA. It binds to the aryl hydrocarbon receptor (AHR), which is involved in mediating toxic effects of certain environmental pollutants. CH-223191 has been shown to be an AHR antagonist, preventing activation of proinflammatory cytokines such as IL-6 and IL-8 in human hepg2 cells. This agent also inhibits the expression of proinflammatory genes, including MMP-9, COX-2, and TNF-α. Additional studies have shown that CH-223191 has lead optimization potential for anticancer drugs due to its ability to inhibit proliferation and induce apoptosis in cancer cells at low levels.</p>Formel:C19H19N5OReinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:333.40 g/mol1-Methyl-N-(2-methyl-4-(o-tolyldiazenyl)phenyl)-1H-pyrazole-5-carboxamide
CAS:Formel:C19H19N5OReinheit:98%Molekulargewicht:333.395







